Fatal bronchiolitis obliterans complicating Stevens–Johnson syndrome following treatment with nimesulide: a case report
Authors:
- D SuriDSD Suri
- A G SainiASA G Saini
- A RawatARA Rawat
- K S SodhiKSK S Sodhi
- 1 August 2011
- journal article
- case report
- Published by Taylor & Francis in Paediatrics and International Child Health
- Vol. 31 (3) , 259-261
Abstract
Nimesulide is a frequently used non-steroidal anti-inflammatory drug with analgesic and antipyretic effects in children. In view of fatal adverse drug reactions, however, its safety has been questioned. A 5-year-old boy developed Stevens-Johnson syndrome following use of nimesulide which was later complicated by rapidly progressive fatal bronchiolitis obliterans.Keywords
This publication has 9 references indexed in Scilit:
- Bronchiolitis obliterans in childrenCurrent Opinion in Pediatrics, 2008
- Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-StudyJournal of Investigative Dermatology, 2008
- Nimesulide-induced hepatitis and toxic epidermal necrolysisJournal of Postgraduate Medicine, 2008
- Bronchiolitis obliterans in children: Clinical presentation, therapy and long‐term follow‐upJournal of Paediatrics and Child Health, 2007
- Bronchiolitis Obliterans: A Rare Chronic Pulmonary Complication Associated with Stevens-Johnson SyndromePediatric Dermatology, 2007
- Chronic pulmonary complications associated with toxic epidermal necrolysis: Report of a severe case with anti‐Ro/SS‐A and a review of the published workThe Journal of Dermatology, 2006
- Acute generalized exanthematous pustulosis induced by nimesulideDermatology Online Journal, 2006
- Fatal hepatotoxicity secondary to nimesulideEuropean Journal of Clinical Pharmacology, 2001
- Fatal hepatitis and renal failure during treatment with nimesulideJournal of Internal Medicine, 2000